Zusammenfassung
In den letzten Jahren ist das Interesse an pflanzlichen Wirkstoffen und Arzneimitteln hinsichtlich ihrer Einsatzmöglichkeiten zur Behandlung von Hautkrankheiten stark gestiegen. Seitens der durch das deutsche Gesundheitsministerium berufenen Kommission E wurden (1987–1995) sog. Positivmonographien für die Anwendung bestimmter Phytopharmaka u. a. für diverse dermatologische Indikationen erstellt. Im Rahmen dieses Fortbildungsartikels werden unter besonderer Berücksichtigung pharmakologischer Grundlagen und Wirksamkeitsstudien phytotherapeutische Behandlungsmöglichkeiten von Hauterkrankungen durch ausgewählte Arzneipflanzen mit dermatologischer Positivmonographie aufgezeigt und der therapeutische Einsatz einiger „Modepflanzen“ diskutiert. Dermatologische Indikationen, Therapiehinweise und Angaben zu Rezepturen, Fertigarzneimitteln sowie mögliche Nebenwirkungen verschiedener Arzneipflanzen und ihr Potenzial zur Induktion sog. Phytodermatitiden werden im Einzelnen erläutert.
Abstract
In the recent years there has been increasing interest in herbal therapy including its use for treatment of dermatologic disorders. In Germany, a regulatory authority known as “Commission E” performed an extensive review of common phytotherapeutic (1987–1995) agents indicating quality of evidence, clinical efficacy and therapeutic usefulness producing a “positive monograph” indicating agents supported by evidence and likely to be useful. This article explores the therapeutic use of several of these and other currently popular plants suitable for dermatologic indications; therapeutic hints including phytotherapeutic products and formulations are given and side effects, in particular toxic and allergic skin reactions, are discussed.
Literatur
Aertgeerts P, Albring M, Klaschka F et al. (1985) Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases. Z Hautkr 60:270–277
Albring M, Albrecht H, Alcorn G, Lucker PW (1983) The measuring of the antiinflammatory effect of a compound on the skin of volunteers. Methods Find Exp Clin Pharmacol 5:575–577
Bassett IB, Pannowitz DL, Barnetson RS (1990) A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 153:455–458
Braun H, Frohne D (1994) Heilpflanzenlexikon. Wirkungen, Verordnungen, Selbstmedikation. Gustav Fischer, Stuttgart
Buck DS, Nidorf DM, Addino JG (1994) Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 38:601–605
Diehm C, Trampisch HJ, Lange S, Schmidt C (1996) Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347:292–294
Eggermont AM, Kleeberg UR, Ruiter DJ, Suciu S (2001) European Organization for Research and Treatment of Cancer Melanoma Group. Trial experience with more than 2,000 patients, evaluating adjuvant treatment with low or intermediate doses of interferon alpha-2b. In: Perry MC (ed) American Society of Clinical Oncology. Educational Book (37th Annual Meeting). Alexandria, pp 88–93
Ellis CN, Berberian B, Sulica VI et al. (1993) A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 29:438–442
Ernst E, Huntley A (2000) Tea tree oil: a systematic review of randomized clinical trials. Forsch Komplementarmed Klass Naturheilkd 7:17–20
Hammer KA, Carson CF, Riley TV (2002) In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 50:195–199
Hausen BM, Busker E, Carle R (1984) The sensitizing capacity of composite plants. VII. Experimental studies with extracts and compounds of Chamomilla recutita (L.) Rauschert and Anthemis cotula L. Planta Med 50:229–234
Heggers JP, Robson MC, Manavalen K et al. (1987) Experimental and clinical observations on frostbite. Ann Emerg Med 16:1056–1062
Knuesel O, Weber M, Suter A (2002) Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial. Adv Ther 19:209–218
Korting HC, Schafer-Korting M, Klovekorn W et al. (1995) Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 48:461–465
Kurkcuoglu N, Alaybeyi F (1990) Topical capsaicin for psoriasis. Br J Dermatol 123:549–550
Lacey CJ, Goodall RL, Tennvall GR et al. (2003) Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 79:270–275
Maiche AG, Grohn P, Maki-Hokkonen H (1991) Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30:395–396
McCauley RL, Heggers JP, Robson MC (1990) Frostbite. Methods to minimize tissue loss. Postgrad Med 88:67–77
Munn SE, Burrows NP, Abadia-Molina F et al. (1997) The effect of topical capsaicin on substance P immunoreactivity: a clinical trial and immunohistochemical analysis. Acta Derm Venereol 77:158–159
Niedner R (1996) Solanum dulcamara L. — ein „Pflanzen-Cortison“? Med Monatsschr Pharm 19:339–340
Nissen HP, Biltz H, Kreysel HW (1988) Profilometrie, eine Methode zur Beurteilung der therapeutischen Wirsamkeit von Kamillosan®-Salbe. Z Hautkr 63:184–190
Oestreich W (1995) Topische Ekzemtherapie mit einem Phytopharmakon — eine multizentische Studie. Hautnah Derm 11:184–189
Patzelt-Wenczler R, Ponce-Poschl E (2000) Proof of efficacy of Kamillosan(R) cream in atopic eczema. Eur J Med Res 5:171–175
Paulsen E (2002) Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis 47:189–198
Pommier P, Gomez F, Sunyach MP et al. (2004) Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22:1447–1453
Reider N, Komericki P, Hausen BM et al. (2001) The seamy side of natural medicines: contact sensitization to arnica (Arnica montana L.) and marigold (Calendula officinalis L.). Contact Dermatitis 45:269–272
Ribereau-Gayon G, Jung ML, Frantz M, Anton R (1997) Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album or misteltoe lectins. Anticancer Drugs, pp 3–8
Syed TA, Ahmad SA, Holt AH et al. (1996) Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1:505–509
Szeimies RM, Stolz W, Wlotzke U et al. (1994) Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 131:380–382
Tarng DC, Cho YL, Liu HN, Huang TP (1996) Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron 72:617–622
Thomas DR, Goode PS, LaMaster K, Tennyson T (1998) Acemannan hydrogel dressing versus saline dressing for pressure ulcers. A randomized, controlled trial. Adv Wound Care 11:273–276
Tupker RA, Coenraads PJ, van der Meer JB (1992) Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol 72:463
Vazquez JA (2002) Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin Trials 3:379–385
Wallengren J (1991) Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 24:286–288
Wallengren J, Klinker M (1995) Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 32:287–289
Weber K, Mengs U, Schwarz T et al. (1998) Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs. Arzneimittelforschung 48:497–502
Wenigmann M (1999) Phytotherapie — Arzneipflanzen, Wirkstoffe, Anwendungen. Urban & Fischer, München
Willital GH, Heine H (1994) Efficacy of Contractubex gel in the treatment of fresh scars after thoracic surgery in children and adolescents. Int J Clin Pharmacol Res 14:193–202
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meyer, S., Vogt, T., Landthaler, M. et al. Einsatz von Phytopharmaka in der Dermatologie. Hautarzt 56, 483–502 (2005). https://doi.org/10.1007/s00105-005-0949-y
Issue Date:
DOI: https://doi.org/10.1007/s00105-005-0949-y